Kimberly-Clark (NASDAQ:KMB) Issues Quarterly Earnings Results

Kimberly-Clark (NASDAQ:KMB) posted its quarterly earnings results on Thursday. The company reported $1.70 earnings per share for the quarter, topping analysts’ consensus estimates of $1.65 by $0.05, FiscalAI reports. The business had revenue of $4.13 billion during the quarter, compared to analyst estimates of $4.13 billion. Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The company’s revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the business posted $1.82 earnings per share.

Here are the key takeaways from Kimberly-Clark’s conference call:

• Kimberly-Clark completed its Kenvue acquisition, bringing together consumer and healthcare brands. Management outlined a phased integration focused first on uninterrupted operations, with about $1.9 billion in targeted cost synergies from overhead, supply-chain and marketing efficiencies.
• Management expects the combined company’s 2027 adjusted EPS to be mid-single-digit dilutive versus standalone Kimberly-Clark, partly reflecting acquired-asset amortization; it expects to return to its growth algorithm in 2028 on a two-year compounded basis.
• Kimberly-Clark maintained its 2026 outlook, citing underlying business momentum, planned fourth-quarter commercial activity, cost-mitigation actions and an easier North America comparison. Executives said Q3 performance was solid despite one-off headwinds, and highlighted strength in tissue and professional products.
• The Huggies business in China remains under pressure after false allegations, although management said authorities confirmed product safety and demand has stabilized. Executives expect the business to remain subdued in Q4 and said rebuilding consumer trust and share will take time.
• Management cited roughly $250 million in gross inflationary impacts for 2026, including elevated North American freight costs, and acknowledged softer recent North America performance amid inventory changes, club-channel distribution shifts and a postponed product launch.

Kimberly-Clark Price Performance

NASDAQ:KMB opened at $107.88 on Friday. The business’s 50-day moving average is $102.62 and its 200 day moving average is $103.19. Kimberly-Clark has a 12 month low of $92.42 and a 12 month high of $116.82. The company has a market capitalization of $35.88 billion, a P/E ratio of 18.34, a P/E/G ratio of 6.28 and a beta of 0.25. The company has a current ratio of 0.91, a quick ratio of 0.69 and a debt-to-equity ratio of 3.45.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on KMB shares. Canaccord Genuity Group started coverage on Kimberly-Clark in a research report on Friday, October 23rd. They issued a “hold” rating and a $105.00 price objective on the stock. Rothschild & Co Redburn decreased their target price on Kimberly-Clark from $138.00 to $129.00 and set a “buy” rating on the stock in a research note on Friday, October 9th. Weiss Ratings restated a “hold (c)” rating on shares of Kimberly-Clark in a research note on Monday, October 26th. UBS Group increased their price objective on shares of Kimberly-Clark from $106.00 to $113.00 and gave the company a “neutral” rating in a report on Wednesday, October 28th. Finally, Wells Fargo & Company lifted their price objective on shares of Kimberly-Clark from $100.00 to $110.00 and gave the company an “equal weight” rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $112.60.

Trending Headlines about Kimberly-Clark

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: KMB earned $1.70 per share, above the $1.65 consensus estimate, and reaffirmed its full-year 2026 adjusted EPS outlook. The earnings beat was attributed in part to lower interest costs. Zacks report on earnings and sales
• Neutral Sentiment: Revenue was $4.13 billion, matching analysts’ expectations, but fell 1.2% year over year. The company’s essential household brands and steady cash generation continue to provide a defensive foundation. Comparison of Kimberly-Clark and Lululemon
• Negative Sentiment: China diaper-related disruptions and lingering reputational damage continued to weigh on sales, while pricing pressures also hurt performance. Some coverage noted that operating profit missed expectations, tempering the headline EPS beat. Reuters report on China sales headwinds
• Negative Sentiment: The completed Kenvue deal adds debt, creating an additional balance-sheet consideration for investors as Kimberly-Clark integrates the business. Report on Kenvue-related debt

Kimberly-Clark Company Profile

Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.